Phase 2 Readout
SXTP: Phase 2 Readout: tafenoquine
October 30, 2026 · tafenoquine. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- October 30, 2026
- Company
- 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
- Drug
- tafenoquine
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout
Phase 2 Readout: tafenoquine
- Drug
- tafenoquine
- Indication
- severe babesiosis